Benzinga | Mar 8, 2021 06:17AM EST

HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Lowers Price Target to $7

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Evofem Biosciences (NASDAQ:EVFM) with a Buy and lowers the price target from $8 to $7.